Botulinum toxin therapy for skin disorders
AssigneeAllergan, Inc.
InventorEric R. First
Life of this patent
Estimating the term…
Abstract
Methods for treating skin disorders by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a skin disorder.
Claims6
A method for reducing the occurrence or alleviating a melanin related affliction in a patient in need thereof, the method comprising the step of locally administering a therapeutically effective amount of a botulinum toxin to an area affected by the melanin related affliction, thereby reducing the occurrence or alleviating the melanin related affliction, wherein the melanin related affliction is selected from the group consisting of dermatofibromas, freckles and atypical moles (dysplastic nevi).
Dependencies are inferred from the claim text.